scholarly journals The Prevalence of Gap Junction Protein Beta 2 (GJB2) Mutations in Non Syndromic Sensorineural Hearing Loss in Çukurova Region

2015 ◽  
Vol 11 (2) ◽  
pp. 118-121 ◽  
Author(s):  
Sevcan Tug Bozdogan ◽  
Gokhan Kuran ◽  
Ozge Ozalp Yüregir ◽  
Huseyin Aslan ◽  
Suheyl Haytoglu ◽  
...  
2012 ◽  
Vol 126 (8) ◽  
pp. 763-769 ◽  
Author(s):  
S Battelino ◽  
B Repič Lampret ◽  
M Žargi ◽  
K Trebušak Podkrajšek

AbstractObjective:Mutations in the gap junction protein beta-2 gene (‘GJB2’) are known to be responsible for mild to profound congenital and late-onset hearing loss. This study aimed to investigate the molecular basis of progressive hearing loss compared with non-progressive hearing loss.Methods:Following clinical otorhinolaryngological evaluation, a genetic analysis was performed in a cohort of 72 patients with progressive sensorineural hearing loss.Results:Pathological genotypes were established in 16 patients (22.2 per cent). Six different gap junction protein beta-2 gene mutations were detected in 15 patients, with the c.35delG mutation responsible for 56 per cent of the mutated alleles. A novel gap junction protein beta-6 gene (‘GJB6’) mutation (p.Met203Val) was observed in one patient with mild progressive hearing loss.Conclusion:Analyses of gap junction protein beta-2 and -6 genes revealed that similar pathological genotypes, occurring with similar frequencies, were responsible for progressive hearing loss, compared with reported genotypes for non-progressive hearing loss patients. Thus, genotype cannot be used to differentiate non-progressive from progressive hearing loss cases; in this study, patients both with and without an established pathological genotype had a similar clinical course.


2008 ◽  
Vol 122 (12) ◽  
pp. 1284-1288 ◽  
Author(s):  
Z Siti Aishah ◽  
M D Mohd Khairi ◽  
A R Normastura ◽  
Z Zafarina ◽  
B A Zilfalil

AbstractObjective:To determine the frequency and type of gap junction protein beta-2 gene mutations in Malay patients with autosomal recessive, non-syndromic hearing loss.Methods:A total of 33 Malay patients with autosomal recessive, non-syndromic hearing loss were screened for mutations in the Cx26 coding region. Deoxyribonucleic acid was extracted from buccal swab samples and subjected to polymerase chain reaction. Slow-reannealing was performed, followed by screening using denaturing high performance liquid chromatography.Results:Eight of the samples (24.2 per cent) showed heterozygous peaks, and further sequencing of these samples revealed four patients (50.0 per cent) with the W24X mutation, two (25.0 per cent) with the V37I mutation and another two (25.0 per cent) with the G4D mutation.Conclusions:Analysis of buccal swab samples by denaturing high performance liquid chromatography is noninvasive and suitable for rapid and reliable screening of gap junction protein beta-2 gene mutations in patients with autosomal recessive, non-syndromic hearing loss. Malay patients with autosomal recessive, non-syndromic hearing loss have different kinds of gap junction protein beta-2 gene mutations which are rarely found in other populations.


2017 ◽  
Vol 21 (2) ◽  
pp. 95-102 ◽  
Author(s):  
Sung Hee Kim ◽  
Rajendra Nepali ◽  
Myung Hoon Yoo ◽  
Kwang-Sun Lee ◽  
Jong Woo Chung

2004 ◽  
Vol 261 (5) ◽  
pp. 259-261 ◽  
Author(s):  
N. Eleftheriades ◽  
N. Voyiatzis ◽  
M. Grigoriadou ◽  
M. B. Petersen ◽  
T. Iliades ◽  
...  

2019 ◽  
Vol 160 (21) ◽  
pp. 822-828
Author(s):  
Nóra Kecskeméti ◽  
Anita Gáborján ◽  
Magdolna Szőnyi ◽  
Marianna Küstel ◽  
Ildikó Baranyi ◽  
...  

Abstract: Introduction: Congenital sensorineural hearing loss is one of the most common sensory defects affecting 1–3 children per 1000 newborns. There are a lot of causes which result in congenital hearing loss, the most common is the genetic origin, but infection, cochlear malformation or other acquired causes can be reasons as well. Aim: The aim of this study was to establish the etiological factors of congenital profound sensorineural hearing loss in children who underwent cochlear implantation. Results: Our results show that the origin of the hearing loss was discovered in 62.9% of our patients. The most common etiological factor was the c.35delG mutation of the gap junction protein β-2 gene, the allele frequency was 38.7% in our cohort. Infection constituted to 10.1%, and meningitis and cytomegalovirus infection were the second most common cause. 79.9% of our patients received sufficient hearing rehabilitation before the end of the speech development’s period (6 years old), but 11.2% of our cases were still diagnosed late. Conclusions: Based on our data we can state that genetic evaluation is crucial in the diagnostic process of congenital profound sensorineural hearing loss. Sufficient hearing rehabilitation affects the whole life of the child, and by late cochlear implantation the speech development falls behind. We can decrease the ratio of the late implantation with the new protocol of newborn hearing screening, and with sufficient information provided to the colleagues, so the children may be referred to the proper center for rehabilitation without delay. Orv Hetil. 2019; 160(21): 822–828.


2021 ◽  
Author(s):  
Shahan Mamoor

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer (1). We performed discovery of genes associated with epithelial ovarian cancer and of the high-grade serous ovarian cancer (HGSC) subtype, using published microarray data (2, 3) to compare global gene expression profiles of normal ovary or fallopian tube with that of primary tumors from women diagnosed with epithelial ovarian cancer or HGSC. We identified the gene encoding gap junction protein beta 2, GJB2, as among the genes whose expression was most different in epithelial ovarian cancer as compared to the normal fallopian tube. GJB2 expression was significantly higher in high-grade serous ovarian tumors relative to normal fallopian tube. GJB2 expression correlated with overall survival in patients with ovarian cancer. These data indicate that expression of GJB2 is perturbed in epithelial ovarian cancers broadly and in ovarian cancers of the HGSC subtype. GJB2 may be relevant to pathways underlying ovarian cancer initiation (transformation) or progression.


2021 ◽  
Author(s):  
Shahan Mamoor

Breast cancer affects women at relatively high frequency (1). We mined published microarray datasets (2, 3) to determine in an unbiased fashion and at the systems level genes most differentially expressed in the primary tumors of patients with breast cancer. We report here significant differential expression of the gene encoding the gap junction protein beta 2, GJB2, when comparing primary tumors of the breast to the tissue of origin, the normal breast. GJB2 was also differentially expressed in the tumor cells of patients with triple negative breast cancer. Analysis of human survival data revealed that expression of GJB2 in primary tumors of the breast was correlated with overall survival in patients with luminal B and HER2+ subtype cancers, but in a contrary manner. GJB2 may be of relevance to initiation, maintenance or progression of cancers of the female breast.


Sign in / Sign up

Export Citation Format

Share Document